Bicocca Open Archive

Logo unimib boa
PIERUZZI, FEDERICO UMBERTO EMILIO GUGLIE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.879
EU - Europa 4.128
AS - Asia 2.247
SA - Sud America 167
AF - Africa 24
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.460
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.750
IT - Italia 933
SG - Singapore 892
CN - Cina 723
DE - Germania 706
IE - Irlanda 511
SE - Svezia 509
RU - Federazione Russa 407
HK - Hong Kong 324
UA - Ucraina 298
AT - Austria 196
GB - Regno Unito 177
BR - Brasile 136
FR - Francia 115
CA - Canada 108
FI - Finlandia 83
VN - Vietnam 72
DK - Danimarca 63
IN - India 54
NL - Olanda 48
TR - Turchia 48
ID - Indonesia 44
JP - Giappone 38
ES - Italia 23
BE - Belgio 15
MX - Messico 12
CH - Svizzera 9
CO - Colombia 8
AU - Australia 7
IR - Iran 7
SA - Arabia Saudita 7
AR - Argentina 6
PA - Panama 6
PE - Perù 6
CZ - Repubblica Ceca 5
EC - Ecuador 5
EG - Egitto 5
EU - Europa 5
IL - Israele 5
KR - Corea 5
MA - Marocco 5
BD - Bangladesh 4
CL - Cile 4
PL - Polonia 4
UZ - Uzbekistan 4
DZ - Algeria 3
GR - Grecia 3
HU - Ungheria 3
IQ - Iraq 3
LT - Lituania 3
RO - Romania 3
SC - Seychelles 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BG - Bulgaria 2
HR - Croazia 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BO - Bolivia 1
BT - Bhutan 1
EE - Estonia 1
ET - Etiopia 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
Totale 15.460
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.328
Woodbridge 670
Fairfield 669
Singapore 595
Chandler 562
Ashburn 502
Dublin 494
Houston 475
Wilmington 464
Frankfurt am Main 445
Hong Kong 322
Jacksonville 297
Seattle 294
Dearborn 261
New York 231
Cambridge 222
Milan 208
Princeton 194
Vienna 185
Santa Clara 162
Nanjing 141
Lawrence 92
Altamura 91
Beijing 78
Shanghai 62
San Diego 53
Dong Ket 48
Jakarta 43
Lachine 43
Nanchang 42
Guangzhou 41
Falls Church 37
Boardman 32
Lissone 32
Andover 31
Jinan 30
Shenyang 30
Helsinki 29
Council Bluffs 28
London 28
Los Angeles 27
Tianjin 27
Rome 26
Nuremberg 24
Ottawa 24
Pune 24
Changsha 20
Hebei 20
Zhengzhou 19
Ningbo 18
São Paulo 18
Kunming 16
Norwalk 16
Toronto 16
Brussels 15
Fremont 15
Hangzhou 15
Jiaxing 15
Monza 15
Huizen 13
Redmond 13
Edmonton 12
Kocaeli 12
Auburn Hills 11
Dallas 11
Kiev 9
Mountain View 8
Munich 8
Naples 8
Nürnberg 8
San Mateo 8
Taizhou 8
Tokyo 8
Washington 8
Chicago 7
Hefei 7
Leawood 7
Paullo 7
Turin 7
Belo Horizonte 6
Brasília 6
Detroit 6
Duncan 6
Genoa 6
Kilburn 6
Madrid 6
Montréal 6
Saint Louis 6
Taiyuan 6
Xiamen 6
Bari 5
Brno 5
Cinisello Balsamo 5
Ho Chi Minh City 5
Jerusalem 5
Manchester 5
Pavia 5
Pescara 5
Salerno 5
Santiago de Cali 5
Totale 11.257
Salva come PNG Salva come JPEG
Nome #
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 401
Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties 363
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 359
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 311
MALDI imaging in Fabry nephropathy: a multicenter study 306
Microscopic Polyangiitis 287
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 275
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 274
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 257
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 250
Kidney Involvement 248
The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children 243
The putative role of MALDI-MSI in the study of Membranous Nephropathy 243
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 240
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 240
Proteomics for the study of new biomarkers in Fabry disease: State of the art 212
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 210
Usefulness of waist circumference for the identification of childhood hypertension 209
ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo 199
Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey 199
Maternal perception of excess weight in children: a survey conducted by paediatricians in the province of Milan 194
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 193
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 189
Obesity-associated hypertension in childhood: A new epidemic problem 183
A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval 182
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 179
Electrophysiological evidence of ipsilateral reno-renal reflexes in the cat 178
Fusarium solani infection after antimicrobial treatment of a severe bacterial peritonitis: a case report and review of the literature 177
Angiotensin II modulates calponin gene expression in rat vascular smooth muscle cells in vivo 176
Parapelvic cysts, a distinguishing feature of renal Fabry disease 176
Insulin resistance, prehypertension, hypertension and blood pressure values in paediatric age 175
Role of fat distribution indicators in the identification of hypertension in children 173
New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases 171
Renal afferents responsive to chemical and mechanical pelvic stimuli in the rabbit 170
FAbry STabilization indEX (FASTEX): An innovative tool for the assessment of clinical stabilization in Fabry disease 167
Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure 166
Intrafamilial phenotypic variability in four families with Anderson-Fabry disease 164
Warped-average template technique to track on a cycle-by-cycle basis the cardiac filling phases on left ventricular volume 162
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 159
Renal afferents signaling diuretic activity in the cat 156
Results of blood pressure screening in a population of school-aged children in the province of Milan: role of overweight 154
Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population 154
QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium 152
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 150
Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats 148
Adrenergic overdrive in mild renal failure: Regional patterns and relationships with metabolic and cardiac abnormalities 146
Sympathetic activation in cardiovascular and renal disease 146
Atrial fibrillation in end stage renal disease patients: influence of hemodialysis on P wave duration and atrial dimension 145
Anticoagulant-related nephropathy: a pathological note 144
ANCA-associated vasculitis in childhood: Recent advances 142
A novel missense mutation for Fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients 142
Monoclonal gammopathy of renal significance: Systemic involvement by benign condition 141
Angiotensin II increases tissue inhibitor matrix metalloproteinase-2 (TIMP-2) gene expression in rat aorta in vivo 140
Outcome of Different Induction Regimens in Anca-Associated Glomerulonephritis According to the Histopathological Characteristics: the Reassess Study* 138
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 135
Best practices on pregnancy on dialysis: the Italian Study Group on Kidney and Pregnancy 134
Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled Trial 132
Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat 130
Angiotensin II modulates MMP-2/TIMP-2 gene expression in rat aorta in vivo 128
Hypertension in childhood: autonomic and metabolic patterns 127
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 127
Possible Pathogenetic Relationship between Fabry Disease and Renal Cell Carcinoma 127
Neuronal nitric oxide synthase and renin stimulation by sodium deprivation are dependent on the renal nerves 126
Redefining the pulvinar sign in fabry disease 126
Effects of erythropoietin administration on blood pressure and urinary albumin excretion in rats 121
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study 121
Avacopan for the treatment of ANCA-associated vasculitis 120
MALDI imaging mass spectrometry in glomerulonephritis: feasibility test 118
Analysis of heart period and arterial pressure variability in childhood hypertension: key role of baroreflex impairment 117
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 114
Angiotensin II increases calponin expression in cultured rat vascular smooth muscle cells 112
Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure 111
Tumour incidence in Fabry disease: A cross-sectional study 111
La terapia enzimatica sostitutiva nella malattia di Fabry 111
[Clinical and histological findings in Fabry nephropathy] 110
Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease 109
Role of the renal nerves in the control of renin synthesis during different sodium intakes in the rat 107
Mutations in the GLA gene and LysoGb3: Is it really Anderson-Fabry disease? 107
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 106
A morphological classification of the fat particles found in the urinary sediment of patients with Fabry disease 104
Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study 103
Effects of adenosine receptor agonists on efferent renal nerve activity in anesthetized rats 102
The children of dialysis: Live-born babies from on-dialysis mothers in Italy - An epidemiological perspective comparing dialysis, kidney transplantation and the overall population 99
Intraoperative diagnosis of Anderson-Fabry disease in patients with obstructive hypertrophic cardiomyopathy undergoing surgical myectomy 96
La diagnosi precoce di malattia 93
SARS-CoV-2 and Hemodialysis: diffusion and mortality in patients and health care team. Reflections from the Lombardy experience 86
Cardiological follow-up in patients with Fabry disease 82
Elevated Ambulatory Blood Pressure Measurements are Associated with a Progressive Form of Fabry Disease 82
Heart involvement in Anderson-Fabry disease: Italian recommendations for diagnostic, follow-up and therapeutic management [Il coinvolgimento cardiaco nella malattia di Anderson-Fabry: Nuove raccomandazioni sulla diagnosi, il follow-up e la terapia] 81
Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders 81
Predictors of Clinical Evolution in Prehypertrophic Fabry Disease 80
Atrial Dysfunction Assessed by Cardiac Magnetic Resonance as an Early Marker of Fabry Cardiomyopathy 75
ECG-based score estimates the probability to detect Fabry Disease cardiac involvement 74
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 71
Renal reflexes and denervation in heart failure 66
The GALA project: Practical recommendations for the use of migalastat in clinical practice on the basis of a structured survey among Italian experts 60
Improving the Annotation Process in Computational Pathology: A Pilot Study with Manual and Semi-automated Approaches on Consumer and Medical Grade Devices 58
Correction to: Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis (Journal of Nephrology, (2020), 10.1007/s40620-020-00774-5) 58
Interpretation of GFR slope in untreated and treated adult Fabry patients 55
Erratum: Erratum to: Relapsing Minimal Change Disease Superimposed on Late-Onset p.N215S Fabry Nephropathy (Clinical Kidney Journal (2022) 15:4 (839) DOI: 10.1093/ckj/sfab148) 52
Totale 15.503
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.795
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020300 0 0 0 0 0 0 0 0 0 114 147 39
2020/20212.474 126 79 210 228 211 251 278 308 218 215 148 202
2021/20221.614 155 198 187 148 115 140 47 81 73 91 117 262
2022/20232.290 255 725 192 177 154 357 27 115 157 15 55 61
2023/20241.660 56 46 53 81 191 506 288 56 119 31 42 191
2024/20252.592 266 395 261 189 345 148 270 133 511 74 0 0
Totale 16.046